Business Standard

Resilient portfolio may help P&G Hygiene recover faster than peers

However, high valuation may restrict immediate gains for the stock

P&G's India growth continues to look up for second straight quarter
Premium

P&G Hygiene is expected to clock around 6 per cent revenue growth in FY21, which is higher than up to 3-4 per cent sales growth estimates for some other HPC players such as Dabur, Marico, etc.

Shreepad S Aute Mumbai
Even as the home and personal care (HPC) segment, which was already under pressure before the Covid-19 outbreak, has taken a further hit, a few products related to hygiene and healthcare stand out. One company that could benefit on this count is Procter & Gamble Hygiene and Health Care (P&G Hygiene), which sells popular consumer products like Whisper (sanitary napkin) and Vicks (cold, cough and flu relief).

Though the company’s top line declined by 6.2 year-on-year (YoY) to Rs 656.1 crore in the March 2020 quarter (Q3), mainly because of Covid-19-led disruptions, it is likely to see a faster recovery than

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in